Development and Evaluation of mHealth Solutions to Monitor and Involve Cardiometabolic Patients in Self-care

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04159558

Enrollment

100

Registered

2019-11-12

Start date

2018-04-24

Completion date

2021-10-31

Last updated

2020-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Copd, Diabetes, Heart Failure, Hypertension, Obesity

Brief summary

To develop, using barcode systems and virtual pillbox (TuMedicina and Alice), an App aimed at patients and carers of patients with cardiometabolic diseases as the main diagnosis, over 45 years of age, who have one or more pathologies and use one or more drugs on a daily basis and to analyze their effectiveness in terms of achieving therapeutic objectives, self-efficacy and self-efficacy in self-care or provision of care (as the case may be), healthy behavior, therapeutic compliance and safe use of medication.

Detailed description

In order to achieve the objective of this study, an experimental study will carry out on patients with cardiometabolic and respiratory diseases and their caregivers. A participation of 100 patients and 85 caregivers is planned. The aim is for them to use the mobile application developed over three months in order to evaluate their health improvement comparing several clinical and analytic parameters before and after the use of the App, and also evaluating the satisfaction of the participants.

Interventions

DEVICEMobile application

Experimental group will use a mobile application to help them in their self-care

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Cardio-metabolic disease, respiratory disease or neurologic disease

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Satisfaction with the mobile application assessed by an ad hoc questionnaire	3 months	% of participants who were satisfied with the mobile application assessed by an ad hoc questionnaire

Secondary

Measure	Time frame	Description
Treatment adherence assessed by Morisky Medication Adherence Scale (MMAS)	3 months	% of participants who improve their treatment adherence assessed by Morisky Medication Adherence Scale (MMAS)

Other

Measure	Time frame	Description
Health goals compliance assessed by an ad hoc questionnaire	3 months	% of participants who compliance their health goals assessed by an ad hoc questionnaire

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026